It could mean that more than one subpopulation with stem cell abilities may exist in the same tumor (CD44+/CD90− epithelial cancer stem cells [46] and CD44+/CD90+ tumor stem cells formed by EMT). The gene discussed is THY1; the disease is neoplasm.